Where is Elysium located?

Elysium is headquartered in New York City, United States.

How many employees does Elysium have?

As of Oct 31, 2026, the latest employee count at Elysium is 87.

Is Elysium a funded company?

Elysium is a funded company, having raised a total of $71.2M across 9 funding rounds to date. The company's 1st funding round was a $***** Series A round.

How much is Elysium worth?

The latest valuation of Elysium is $***** as of Dec 06, 2016.

When was the latest funding round of Elysium?

Elysium's latest funding was a $***** Grant (prize money) round on May 22, 2025, with participation from 1 investor.

Where does Elysium rank among its competitors?

Elysium ranks 1st amongst 90 active competitors, of which 11 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was REGENESOME, which secured $137K in Sep, 2025.

Who are the top competitors of Elysium?

Elysium's top competitors include Timeline, Amazentis and NOVOS. Among them, REGENESOME secured the most recent funding round in September, 2025.

Elysium - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer and manufactures of cellular health supplements. The products help in a daily formulation for repairing key metabolic processes, including DNA repair, cellular toxicity, energy production, and protein folding. It contains two compounds found in nature that are nicotinamide riboside (NR), a precursor to NAD+, and pterostilbene, a polyphenol.

Website: www.elysiumhealth.com/
Social
Email ID: *****@elysiumhealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

New York City, United States

Stage

Series C

Total Funding

$71.2M in 9 rounds

Latest Funding Round

Grant (prize money), May 22, 2025, $*****

Post Money Valuation

$***** as on Dec 06, 2016

Investors

General Catalyst & 20 more

Ranked

1^st among 90 active competitors

Employee Count

87 as on Oct 31, 2026

Similar Companies

Timeline & 91 more

View Elysium's full profile

Elysium has raised a total funding of $71.2M over 9 rounds. Its latest funding round was a Grant (prize money) round on May 22, 2025 for $*****. 1 investor participated in its latest round. Elysium has 18 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Elysium:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 22, 2025	4623770	Grant (prize money)	1713369	2867666	1757760	4319617
Jun 01, 2023	8587697	Grant (prize money)	2080377	2303814	8280949	HHS
Sep 21, 2021	2421191	Series C	1755195	9531516	The Venture Collective & 1 more	6946562

Access funding benchmarks and valuations. Sign up today!

View details of Elysium's funding rounds and investors

The founders of Elysium are Eric Marcotulli and Leonard Guarente.

Here are the details of Elysium's key team members:

Eric Marcotulli: Co-Founder & CEO of Elysium.
Leonard Guarente: Co-Founder & CSO of Elysium.
Contact Info: 1 email address

View details of Elysium's Founder profiles and Board Members

Elysium's employee count trend

Elysium has 87 employees as of Oct 26. Here is Elysium's employee count trend over the years:

Uncover Elysium's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Elysium include Timeline, Amazentis and NOVOS. Here is the list of Top 10 competitors of Elysium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Elysium 2014, New York City (United States), Series C	Developer and manufactures of cellular health supplements	$71.2M	Western Technology Investment, SVB & 19 others	71/100
2nd	Timeline 2007, Lausanne (Switzerland), Seed	Developer of clinically-tested Urolithin A supplements and skincare products	-	BOLD, Climb Ventures & 2 others	48/100
3rd	Amazentis 2007, Lausanne (Switzerland), Series C	Developing nutritional products to slow aging and improve quality of life	$8.9M	Nestlé Health Science, Waypoint Capital & 2 others	46/100
4th	NOVOS 2019, New York City (United States), Seed	Develops nutraceuticals to slow down aging	$3.15M	Resolute Ventures, Uncommon Denominator & 5 others	45/100
5th	Tally Health 2021, New York City (United States), Seed	Provider of biological age testing kits and cellular health supplements	$10M	Forerunner Ventures, L Catterton & 2 others	44/100
6th	Glutone 2018, Mumbai (India), Unfunded	Provider of glutathione supplements and skincare products	-	-	42/100
7th	aeternum Zollikofen (Switzerland), Unfunded	Retailer of supplements and test kits focused on anti-aging solutions	-	-	34/100
8th	Wonderfeel 2018, San Francisco (United States), Unfunded	Wellness biosciences company that focuses on longevity	-	-	33/100
9th	REGENESOME 2024, Minato (Japan), Seed	Developer of supplements, foods, and cosmetics using exosome technology	$137K	Leave a Nest	31/100
10th	Optigenex 2002, Scottsdale (United States), Public	Patented healthy aging technology for supplement and skincare industries	-	-	30/100